CD1A and melanoma: Increased PDCs have been described in melanoma, squamous cell carcinoma, basal cell carcinoma, and cutaneous T cell lymphoma [47,48] In the peritumoral area of melanoma patients, Vermi et al. demonstrated a large number of PDCs with a minor subset of mature CD1a(+) DCs.